Overview
- 13 inspections across 13 sites are on record.
- 48 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-02-28.
At a glance
Inspections
13
Sites
13
Observations
48
Career since
Oct 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| N-Molecular, Inc. dba SOFIE | 28 Feb 2018 | Human Drugs | View 483 → |
| Azurity Pharmaceuticals, Inc. | 20 Dec 2017 | Human Drugs | |
| Merit Pet Products, LLC | 6 Oct 2017 | Animal Drugs & Feeds | View 483 → |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 28 Jul 2017 | Human Drugs | View 483 → |
| Pfizer, Inc. | 7 Jun 2017 | Human Drugs | View 483 → |
Sites inspected
N-Molecular, Inc. dba SOFIEHaverhill, United States1 insp.
Azurity Pharmaceuticals, Inc.Woburn, United States1 insp.
Merit Pet Products, LLCCumberland, United States1 insp.
Boehringer Ingelheim Pharmaceuticals, Inc.Ridgefield, United States1 insp.
Pfizer, Inc.Groton, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Full investigator report
Get the verbatim findings behind Christopher Janik's 48 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site